全文获取类型
收费全文 | 321291篇 |
免费 | 18623篇 |
国内免费 | 11383篇 |
专业分类
耳鼻咽喉 | 4198篇 |
儿科学 | 10361篇 |
妇产科学 | 3822篇 |
基础医学 | 26679篇 |
口腔科学 | 4881篇 |
临床医学 | 40316篇 |
内科学 | 46534篇 |
皮肤病学 | 3335篇 |
神经病学 | 26567篇 |
特种医学 | 17963篇 |
外国民族医学 | 25篇 |
外科学 | 53128篇 |
综合类 | 36300篇 |
现状与发展 | 29篇 |
一般理论 | 1篇 |
预防医学 | 18945篇 |
眼科学 | 6228篇 |
药学 | 31399篇 |
121篇 | |
中国医学 | 8122篇 |
肿瘤学 | 12343篇 |
出版年
2023年 | 3296篇 |
2022年 | 6158篇 |
2021年 | 13836篇 |
2020年 | 8665篇 |
2019年 | 13795篇 |
2018年 | 8570篇 |
2017年 | 8208篇 |
2016年 | 10254篇 |
2015年 | 13027篇 |
2014年 | 23785篇 |
2013年 | 22838篇 |
2012年 | 24416篇 |
2011年 | 22064篇 |
2010年 | 19949篇 |
2009年 | 19164篇 |
2008年 | 17804篇 |
2007年 | 17814篇 |
2006年 | 15485篇 |
2005年 | 11257篇 |
2004年 | 7048篇 |
2003年 | 6279篇 |
2002年 | 5204篇 |
2001年 | 4398篇 |
2000年 | 3886篇 |
1999年 | 2909篇 |
1998年 | 3082篇 |
1997年 | 2862篇 |
1996年 | 2364篇 |
1995年 | 2261篇 |
1994年 | 2066篇 |
1993年 | 1633篇 |
1992年 | 1845篇 |
1991年 | 1587篇 |
1990年 | 1623篇 |
1989年 | 1517篇 |
1988年 | 1365篇 |
1987年 | 1237篇 |
1986年 | 1062篇 |
1985年 | 2130篇 |
1984年 | 2177篇 |
1983年 | 1579篇 |
1982年 | 1649篇 |
1981年 | 1617篇 |
1980年 | 1428篇 |
1979年 | 1151篇 |
1978年 | 877篇 |
1977年 | 885篇 |
1976年 | 771篇 |
1974年 | 500篇 |
1973年 | 489篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
目的探讨短时程脊髓电刺激(temporary spinal cord stimulation, tSCS)治疗爆发痛合并触诱发痛的急性期带状疱疹的临床疗效。方法回顾性地分析同济大学附属第十人民医院疼痛科2020年1月—2020年12月收治的52例接受tSCS治疗的爆发痛合并触诱发痛的急性期带状疱疹患者的临床资料,评估在治疗前、治疗后3d、7d、14d、3个月、6个月的总体疼痛情况(numerical rating scale, NRS)评分、(simple McGill scores, McGill)评分、爆发痛情况(发生率、NRS评分、次数以及持续时间)、触诱发痛情况(发生率、分级)、术后不良反应等;评估在治疗前、治疗后7d、3个月、6个月的睡眠时长、睡眠中醒来次数、疼痛障碍指数(pain disorder index, PDI)、功能状态评分(Karnofsky score, KPS)、抑郁症筛查量表(patient health questionnaire depression module scale, PHQ-9)和焦虑症筛查量表(generalized anxiety disorder-7 scale, GAD-7)等。结果与治疗前相比,治疗后3d、7d、14d、3个月、6个月的总体疼痛NRS评分、总体疼痛MCGILL评分、静息痛NRS评分明显降低(均P<0.001);与治疗前相比,治疗后3d、7d、14d、3个月、6个月的的爆发痛NRS评分明显降低(均P<0.05),治疗后14d、3个月、6个月时的爆发痛次数以及持续时间都明显降低(均P<0.05);与治疗前比较,患者治疗后7d、14d、3个月、6个月时的触诱发痛的分级都明显降低,差异均有统计学意义(均P<0.05);与治疗前相比,治疗后14d、3个月、6个月的PDI评分明显降低(P<0.05);与治疗前相比,治疗后14d、3个月、6个月的PHQ-9评分和GAD-7评分都明显减少(P<0.05),与术前的药物使用情况相比,治疗后各镇痛药使用人数普遍呈下降趋势;术中及整个随访期间未观察到严重不良事件。结论短时程脊髓电刺激对爆发痛合并触诱发痛的急性期带状疱疹具有较好的临床疗效。 相似文献
12.
13.
《Clinical neurophysiology》2021,132(10):2357-2364
ObjectivesTo investigate the subcortical somatosensory evoked potentials (SEPs) to electrical stimulation of either muscle or cutaneous afferents.MethodsSEPs were recorded in 6 patients suffering from Parkinson’s disease (PD) who underwent electrode implantation in the pedunculopontine (PPTg) nucleus area. We compared SEPs recorded from the scalp and from the intracranial electrode contacts to electrical stimuli applied to: 1) median nerve at the wrist, 2) abductor pollicis brevis motor point, and 3) distal phalanx of the thumb. Also the high-frequency oscillations (HFOs) were analysed.ResultsAfter median nerve and pure cutaneous (distant phalanx of the thumb) stimulation, a P1-N1 complex was recorded by the intracranial lead, while the scalp electrodes recorded the short-latency far-field responses (P14 and N18). On the contrary, motor point stimulation did not evoke any low-frequency component in the PPTg traces, nor the N18 potential on the scalp. HFOs were recorded to stimulation of all modalities by the PPTg electrode contacts.ConclusionsStimulus processing within the cuneate nucleus depends on modality, since only the cutaneous input activates the complex intranuclear network possibly generating the scalp N18 potential.SignificanceOur results shed light on the subcortical processing of the somatosensory input of different modalities. 相似文献
14.
Mette Nissen Tiina‐Mari Ikheimo Jukka Huttunen Ville Leinonen Henna‐Kaisa Jyrkknen Mikael von und zu Fraunberg 《Neuromodulation》2021,24(1):102-111
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation. 相似文献
15.
Hannah C. Nordhues Anjali Bhagra Natya N. Stroud Jennifer A. Vencill Carol L. Kuhle 《Mayo Clinic proceedings. Mayo Clinic》2021,96(7):1907-1920
The coronavirus disease 2019 (COVID-19) pandemic has rapidly created widespread impacts on global health and the economy. Data suggest that women are less susceptible to severe illness. However, sex-disaggregated data are incomplete, leaving room for misinterpretation, and focusing only on biologic sex underestimates the gendered impact of the pandemic on women. This narrative review summarizes what is known about gender disparities during the COVID-19 pandemic and the economic, domestic, and health burdens along with overlapping vulnerabilities related to the pandemic. In addition, this review outlines recommended strategies that advocacy groups, community leaders, and policymakers should implement to mitigate the widening gender disparities related to COVID-19. 相似文献
16.
17.
18.
19.
20.